Pfaller Christian K, Mastorakos George M, Matchett William E, Ma Xiao, Samuel Charles E, Cattaneo Roberto
Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA Virology and Gene Therapy Track, Mayo Graduate School, Mayo Clinic, Rochester, Minnesota, USA.
J Virol. 2015 Aug;89(15):7735-47. doi: 10.1128/JVI.01017-15. Epub 2015 May 13.
Defective interfering RNAs (DI-RNAs) of the viral genome can form during infections of negative-strand RNA viruses and outgrow full-length viral genomes, thereby modulating the severity and duration of infection. Here we document the frequent de novo generation of copy-back DI-RNAs from independent rescue events both for a vaccine measles virus (vac2) and for a wild-type measles virus (IC323) as early as passage 1 after virus rescue. Moreover, vaccine and wild-type C-protein-deficient (C-protein-knockout [CKO]) measles viruses generated about 10 times more DI-RNAs than parental virus, suggesting that C enhances the processivity of the viral polymerase. We obtained the nucleotide sequences of 65 individual DI-RNAs, identified breakpoints and reinitiation sites, and predicted their structural features. Several DI-RNAs possessed clusters of A-to-G or U-to-C transitions. Sequences flanking these mutation sites were characteristic of those favored by adenosine deaminase acting on RNA-1 (ADAR1), which catalyzes in double-stranded RNA the C-6 deamination of adenosine to produce inosine, which is recognized as guanosine, a process known as A-to-I RNA editing. In individual DI-RNAs the transitions were of the same type and occurred on both sides of the breakpoint. These patterns of mutations suggest that ADAR1 edits unencapsidated DI-RNAs that form double-strand RNA structures. Encapsidated DI-RNAs were incorporated into virus particles, which reduced the infectivity of virus stocks. The CKO phenotype was dominant: DI-RNAs derived from vac2 with a CKO suppressed the replication of vac2, as shown by coinfections of interferon-incompetent lymphatic cells with viruses expressing different fluorescent reporter proteins. In contrast, coinfection with a C-protein-expressing virus did not counteract the suppressive phenotype of DI-RNAs.
Recombinant measles viruses (MVs) are in clinical trials as cancer therapeutics and as vectored vaccines for HIV-AIDS and other infectious diseases. The efficacy of MV-based vectors depends on their replication proficiency and immune activation capacity. Here we document that copy-back defective interfering RNAs (DI-RNAs) are generated by recombinant vaccine and wild-type MVs immediately after rescue. The MV C protein interferes with DI-RNA generation and may enhance the processivity of the viral polymerase. We frequently detected clusters of A-to-G or U-to-C transitions and noted that sequences flanking individual mutations contain motifs favoring recognition by the adenosine deaminase acting on RNA-1 (ADAR1). The consistent type of transitions on the DI-RNAs indicates that these are direct substrates for editing by ADAR1. The ADAR1-mediated biased hypermutation events are consistent with the protein kinase R (PKR)-ADAR1 balancing model of innate immunity activation. We show by coinfection that the C-defective phenotype is dominant.
在负链RNA病毒感染过程中,病毒基因组的缺陷干扰RNA(DI-RNA)能够形成,并超越全长病毒基因组,从而调节感染的严重程度和持续时间。在此,我们记录了在病毒拯救后的第1代,疫苗麻疹病毒(vac2)和野生型麻疹病毒(IC323)在独立拯救事件中频繁从头生成回文DI-RNA。此外,疫苗和野生型C蛋白缺陷(C蛋白敲除[CKO])麻疹病毒产生的DI-RNA比亲本病毒多约10倍,这表明C蛋白增强了病毒聚合酶的持续合成能力。我们获得了65个单独DI-RNA的核苷酸序列,确定了断点和重新起始位点,并预测了它们的结构特征。几个DI-RNA具有A到G或U到C转换的簇。这些突变位点两侧的序列是RNA特异性腺苷脱氨酶1(ADAR1)偏好序列的特征,ADAR1在双链RNA中催化腺苷的C-6脱氨反应,产生肌苷,肌苷被识别为鸟苷,这一过程称为A到I RNA编辑。在单个DI-RNA中,转换是同一类型的,并且发生在断点两侧。这些突变模式表明,ADAR1编辑形成双链RNA结构的未包装DI-RNA。包装好的DI-RNA被整合到病毒颗粒中,这降低了病毒储备的感染性。CKO表型是显性的:如用表达不同荧光报告蛋白的病毒对无干扰素的淋巴细胞进行共感染所示,源自具有CKO的vac2的DI-RNA抑制了vac2的复制。相反,与表达C蛋白的病毒共感染并不能抵消DI-RNA的抑制表型。
重组麻疹病毒(MV)正在作为癌症治疗药物以及用于HIV-艾滋病和其他传染病的载体疫苗进行临床试验。基于MV的载体的功效取决于它们的复制能力和免疫激活能力。在此,我们记录了重组疫苗和野生型MV在拯救后立即产生回文缺陷干扰RNA(DI-RNA)。MV C蛋白干扰DI-RNA的产生,并可能增强病毒聚合酶的持续合成能力。我们经常检测到A到G或U到C转换的簇,并注意到单个突变两侧的序列包含有利于被RNA特异性腺苷脱氨酶1(ADAR1)识别的基序。DI-RNA上一致的转换类型表明,这些是ADAR1编辑的直接底物。ADAR1介导的偏向性超突变事件与先天免疫激活的蛋白激酶R(PKR)-ADAR1平衡模型一致。我们通过共感染表明,C缺陷表型是显性的。